| Titolo |
Pubblicato in |
Anno |
| The still under-investigated role of cognitive deficits in PML diagnosis |
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS |
2017 |
| Dalfampridine improves cognition impairment in multiple sclerosis (MS): results from a randomised, double-blind, placebo-controlled trial. |
issuu.com/americanacademyofneurology/docs/17am_scienceprogramdigi_v716 |
2017 |
| Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) |
JOURNAL OF NEUROLOGY |
2017 |
| The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2017 |
| Association between BKPyV Serotype i Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy |
VIRAL IMMUNOLOGY |
2017 |
| Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy |
NEUROEPIDEMIOLOGY |
2017 |
| Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach |
NEUROLOGICAL SCIENCES |
2017 |
| High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2017 |
| Prognostic indicators in pediatric clinically isolated syndrome |
ANNALS OF NEUROLOGY |
2017 |
| Survey of diagnostic and treatment practices for multiple sclerosis in Europe |
EUROPEAN JOURNAL OF NEUROLOGY |
2017 |
| Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis |
NEW ENGLAND JOURNAL OF MEDICINE |
2017 |
| Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study |
MULTIPLE SCLEROSIS |
2017 |
| Baseline characteristics associated with NEDA-3 status in fingolimod-treated patients with relapsing-remitting multiple sclerosis |
MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS |
2017 |
| Assessing response to interferon-β in a multicenter dataset of patients with MS |
NEUROLOGY |
2016 |
| The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence |
HUMAN BRAIN MAPPING |
2016 |
| Multiple sclerosis: Changes in thalamic resting-State functional connectivity induced by A homebased cognitive rehabilitation program |
RADIOLOGY |
2016 |
| A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis |
NEUROLOGY |
2016 |
| Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2016 |
| A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta |
MULTIPLE SCLEROSIS AND RELATED DISORDERS |
2016 |
| Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2016 |
